Literature DB >> 12428908

Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs.

Laura Bungener1, Anke Huckriede, Jan Wilschut, Toos Daemen.   

Abstract

The induction of effective cellular and humoral immune responses against protein antigens is of major importance in vaccination strategies against infectious diseases and cancer. Immunization with protein alone in general does not result in efficient induction of cytotoxic T lymphocyte (CTL) and antibody responses. Numerous other immunization strategies have been explored. In this review we will discuss a number of lipid-based antigen delivery systems suitable for the induction of CTL responses. These systems comprise reconstituted virus envelopes (virosomes), liposomes, and immune-stimulating complexes (ISCOMs). We will concentrate on delivery of the protein antigen ovalbumin (OVA) since extensive studies with this antigen have been performed for all of the systems discussed, allowing direct comparison of antigen delivery efficiency. Stimulation of CTL activity requires processing of the antigen in the cytosol of antigen-presenting cells (APCs) and presentation of antigenic peptides on surface major histocompatibility class I complexes (MHC class I). In vitro, the ability of antigen delivery systems to induce MHC class I presentation indeed correlates with their capacity to deliver antigen to the cytosol of cells. This capacity appears to be less important for the induction of cytotoxic T lymphocytes in vivo. Instead, other properties of the antigen delivery system like activation of APCs and induction of T helper cells play a more prominent role. Fusion-active virosomes appear to be a very potent system for induction of CTL activity, most likely since virosomes combine efficient delivery of antigen with general stimulation of the immune system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12428908     DOI: 10.1023/a:1020198908574

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  8 in total

1.  Conference report--adjuvants and delivery: improving on vaccine immunogenicity highlights from the viral vaccine meeting; October 25-28, 2003; Barcelona, Spain.

Authors:  Elena Armandola
Journal:  MedGenMed       Date:  2004-01-26

2.  Novel antigen delivery systems.

Authors:  Maria Trovato; Piergiuseppe De Berardinis
Journal:  World J Virol       Date:  2015-08-12

Review 3.  Equine Influenza Virus and Vaccines.

Authors:  Fatai S Oladunni; Saheed Oluwasina Oseni; Luis Martinez-Sobrido; Thomas M Chambers
Journal:  Viruses       Date:  2021-08-20       Impact factor: 5.818

4.  Lipoidal soft hybrid biocarriers of supramolecular construction for drug delivery.

Authors:  Dinesh Kumar; Deepak Sharma; Gurmeet Singh; Mankaran Singh; Mahendra Singh Rathore
Journal:  ISRN Pharm       Date:  2012-07-19

5.  Advanced antigen delivery of murine survivin: chimeric virus-like particles in cancer vaccine research.

Authors:  Thomas Schumacher; Claus Ruehland; Christine Schultheiss; Marc Brinkman; Franz Roedel; Christian O A Reiser; Juergen Hess; Christoph Reichel
Journal:  Int J Biomed Sci       Date:  2007-09

6.  Strategies for intranasal delivery of vaccines.

Authors:  Mehfuz Zaman; Saranya Chandrudu; Istvan Toth
Journal:  Drug Deliv Transl Res       Date:  2012-07-12       Impact factor: 4.617

Review 7.  A Systematic Review of Recent Advances in Equine Influenza Vaccination.

Authors:  Romain Paillot
Journal:  Vaccines (Basel)       Date:  2014-11-14

8.  Pulmonary Delivery of Virosome-Bound Antigen Enhances Antigen-Specific CD4+ T Cell Proliferation Compared to Liposome-Bound or Soluble Antigen.

Authors:  Rebecca A M Blom; Mario Amacker; R Maarten van Dijk; Christian Moser; Philip A Stumbles; Fabian Blank; Christophe von Garnier
Journal:  Front Immunol       Date:  2017-04-07       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.